Clinical Trial Update: A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 study assessing how AZD6793 affects the pharmacokinetics and pharmacodynamics of metformin in participants with type 2 diabetes mellitus, currently susp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD6793
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: SUSPENDED